(2,4-Dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) O (4),O (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) O (4),O (5))bis­(1,10-phenanthroline-κ(2) N,N′)yttrium(III) dihydrate

In the title compound, [Y(C(5)H(2)N(2)O(4))(C(5)H(3)N(2)O(4))(C(12)H(8)N(2))(2)]·2H(2)O, the Y(III) ion lies on a twofold rotation axis and exhibits a distorted square-anti­prismatic coordination geometry. It is chelated by two 1,10-phenanthroline ligands, a 2,4-dioxo-1,2,3,4-tetra­hydro­pyrimidine-...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Wei, Xing, Huihui, Su, Yan, Chen, Zilu
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2008
Materias:
Metal-Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2960551/
https://www.ncbi.nlm.nih.gov/pubmed/21201614
http://dx.doi.org/10.1107/S1600536808025701
_version_ 1782188767144050688
author Xiong, Wei
Xing, Huihui
Su, Yan
Chen, Zilu
author_facet Xiong, Wei
Xing, Huihui
Su, Yan
Chen, Zilu
author_sort Xiong, Wei
collection PubMed
description In the title compound, [Y(C(5)H(2)N(2)O(4))(C(5)H(3)N(2)O(4))(C(12)H(8)N(2))(2)]·2H(2)O, the Y(III) ion lies on a twofold rotation axis and exhibits a distorted square-anti­prismatic coordination geometry. It is chelated by two 1,10-phenanthroline ligands, a 2,4-dioxo-1,2,3,4-tetra­hydro­pyrimidine-5-carboxyl­ate mono­anion and a 4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ate dianion. The H atom involved in an N—H⋯N hydrogen bond between the 1,2-dihydro­pyrimidine units has half occupancy and is disordered around a twofold rotation axis.
format Text
id pubmed-2960551
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29605512010-12-30 (2,4-Dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) O (4),O (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) O (4),O (5))bis­(1,10-phenanthroline-κ(2) N,N′)yttrium(III) dihydrate Xiong, Wei Xing, Huihui Su, Yan Chen, Zilu Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers In the title compound, [Y(C(5)H(2)N(2)O(4))(C(5)H(3)N(2)O(4))(C(12)H(8)N(2))(2)]·2H(2)O, the Y(III) ion lies on a twofold rotation axis and exhibits a distorted square-anti­prismatic coordination geometry. It is chelated by two 1,10-phenanthroline ligands, a 2,4-dioxo-1,2,3,4-tetra­hydro­pyrimidine-5-carboxyl­ate mono­anion and a 4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ate dianion. The H atom involved in an N—H⋯N hydrogen bond between the 1,2-dihydro­pyrimidine units has half occupancy and is disordered around a twofold rotation axis. International Union of Crystallography 2008-08-16 /pmc/articles/PMC2960551/ /pubmed/21201614 http://dx.doi.org/10.1107/S1600536808025701 Text en © Xiong et al. 2008 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Xiong, Wei
Xing, Huihui
Su, Yan
Chen, Zilu
(2,4-Dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) O (4),O (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) O (4),O (5))bis­(1,10-phenanthroline-κ(2) N,N′)yttrium(III) dihydrate
title (2,4-Dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) O (4),O (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) O (4),O (5))bis­(1,10-phenanthroline-κ(2) N,N′)yttrium(III) dihydrate
title_full (2,4-Dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) O (4),O (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) O (4),O (5))bis­(1,10-phenanthroline-κ(2) N,N′)yttrium(III) dihydrate
title_fullStr (2,4-Dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) O (4),O (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) O (4),O (5))bis­(1,10-phenanthroline-κ(2) N,N′)yttrium(III) dihydrate
title_full_unstemmed (2,4-Dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) O (4),O (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) O (4),O (5))bis­(1,10-phenanthroline-κ(2) N,N′)yttrium(III) dihydrate
title_short (2,4-Dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) O (4),O (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) O (4),O (5))bis­(1,10-phenanthroline-κ(2) N,N′)yttrium(III) dihydrate
title_sort (2,4-dioxo-1,2,3,4-tetra­hydro­pyrimi­dine-5-carboxyl­ato-κ(2) o (4),o (5))(4-oxido-2-oxo-1,2-dihydro­pyrimidine-5-carboxyl­ato-κ(2) o (4),o (5))bis­(1,10-phenanthroline-κ(2) n,n′)yttrium(iii) dihydrate
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2960551/
https://www.ncbi.nlm.nih.gov/pubmed/21201614
http://dx.doi.org/10.1107/S1600536808025701
work_keys_str_mv AT xiongwei 24dioxo1234tetrahydropyrimidine5carboxylatok2o4o54oxido2oxo12dihydropyrimidine5carboxylatok2o4o5bis110phenanthrolinek2nnyttriumiiidihydrate
AT xinghuihui 24dioxo1234tetrahydropyrimidine5carboxylatok2o4o54oxido2oxo12dihydropyrimidine5carboxylatok2o4o5bis110phenanthrolinek2nnyttriumiiidihydrate
AT suyan 24dioxo1234tetrahydropyrimidine5carboxylatok2o4o54oxido2oxo12dihydropyrimidine5carboxylatok2o4o5bis110phenanthrolinek2nnyttriumiiidihydrate
AT chenzilu 24dioxo1234tetrahydropyrimidine5carboxylatok2o4o54oxido2oxo12dihydropyrimidine5carboxylatok2o4o5bis110phenanthrolinek2nnyttriumiiidihydrate

Ejemplares similares